Is CD109 p.Ile206Val (c.616A>G) pathogenic?

CD109 p.Ile206Val (c.616A>G) is classified Benign in CD109 (ClinVar, Multiple submitters, 3 submitters; last evaluated 2026-05-01). AlphaMissense: likely benign (0.1016); Low-frequency (popmax 1.14%, nfe).

How common is CD109 p.Ile206Val (c.616A>G) in the general population?

CD109 p.Ile206Val (c.616A>G) is low-frequency (popmax 1.14%, nfe) (gnomAD).

What do computational predictors say about CD109 p.Ile206Val (c.616A>G)?

AlphaMissense predicts likely benign (score 0.1016) — an in-silico prediction, not a clinical call.

CD109 p.Ile206Val

c.616A>G · rs148575660 · VCV776594

Benign Multiple submitters

Classification

Benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 3 submitters

AlphaMissense

likely benign

0.1016 · ACMG-weighted

gnomAD v4.1

Rare

low-frequency (popmax 1.14%, nfe)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.1016	likely benign
REVEL	0.239	benign-leaning
SaProt	LLR -8.88	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 5.1	GERP 0.59, phastCons 1
Regional constraint	o/e 1.02	unconstrained · MANE · 127 kb · p 0.4 · regional, not allelic
Overall
CADD	22.4	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 1.14% European (non-Finnish) · 13,426/1,179,090 alleles

Filtering AF 1.12% ClinGen BA1/BS1 input FAF95, joint · FAF99 1.12%

Overall 1.03% 16,557/1,612,012 alleles · low-frequency

Ancestry group	Frequency	1 in
Finnishnot grpmax-eligible	1.64%	61
European (non-Finnish)grpmax	1.14%	88
South Asian	1.08%	93
Middle Eastern	0.99%	101
Remaining individualsnot grpmax-eligible	0.94%	106
Ashkenazi Jewishnot grpmax-eligible	0.541%	185
Admixed American	0.319%	314
Amishnot grpmax-eligible	0.219%	456
African / African-American	0.133%	749
East Asian	0.00224%	44,686

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CD109
Protein: p.Ile206Val
Coding: c.616A>G
MANE Select: NM_133493
dbSNP: rs148575660
Type: single nucleotide variant
Location: chr6:73736491 (GRCh38)
Gene constraint: LOEUF 1.092 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 81.42 · 3 PDB
Residue 206: a β-strand

Full CD109 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

CD109 p.Gln416Glu Likely benign ★★ same type
CD109 p.Ala1104Val Uncertain significance ★ ⚠ same type
CD109 p.Ala1115Gly Uncertain significance ★ ⚠ same type
CD109 p.Ala1148Gly Uncertain significance ★ ⚠ same type
CD109 p.Ala1190Pro Uncertain significance ★ ⚠ same type
CD109 p.Ala1196Asp Uncertain significance ★ ⚠ same type
CD109 p.Ala1196Val Uncertain significance ★ ⚠ same type
CD109 p.Ala1265Ser Uncertain significance ★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cd109-p-ile206val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown